Some Commentary
It feels strange to be writing about biomedicine, even about a terrible pandemic, under the current circumstances. I was six years old in 1968 and was thus largely spared that year’s events, so 2020 is...
View ArticleSurgisphere and Their Data
So we have a very strange situation with some recent publications, one that deserves a closer look. The ones I refer to are the recent Lancet retrospective study on hydroxychloroquine use (blogged...
View ArticleNot Winning Friends, Not Influencing People
Many chemists will by now be aware of the brief, but very loud, incident with Angewandte Chemie and a paper by Tomas Hudlicky that appeared there. Well, it didn’t appear for long – within hours, the...
View ArticleAfrica, African-Americans, and the Coronavirus Vaccines
I mentioned yesterday in my post about anti-vaccine arguments that there seemed to be suspicions on social media platforms about vaccine testing in Africa. I’ve been looking around for more of that,...
View ArticleA Brief Note on Immigration and American Science
There’s an article out today from John Maraganore (CEO of Alnylam, immediate past chair of the BIO industry group) and his successor at BIO, Jeremy Levin (CEO of Ovid Therapeutics). They’re making the...
View ArticleThe President’s Coronavirus Treatment
I’ve had emails asking me what I think about President Trump’s illness and the course of treatment that he’s under. To be honest, this wasn’t a subject that I really felt like writing about – every...
View ArticleBlood Clots and the AZ Vaccine, Revisited
Once again, what’s going on with vascular events and the AZ/Oxford vaccine? I last wrote about this situation a couple of weeks ago, and it’s taken some real turns since then. At that point several EU...
View ArticleRussian Vaccine Behavior
In the last post, I mentioned the Twitter response to the Brazilian rejection of the Gamaleya vaccine. I believe that the official blue-check-marked “Sputnik V” Twitter account is run by the Russian...
View ArticleWaiving IP
The announcement by the Biden administration about waiving IP rights to the coronavirus vaccines obviously calls for some comment. Keep in mind that I have been doing research in the pharma industry...
View ArticleCoronavirus Origins
I’m going to regret writing about this, but it’s not a topic to be ignored. Where did the current coronavirus come from? If you ask that question, you get all sorts of answers from all sorts of people....
View Article
